Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05985135 · ClinicalTrials.gov registry record · NA
Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT05985135: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT05985135 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05985135, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This research is being done to better understand how insulin effects muscle, blood, and the body in people with Type 1 Diabetes.
Interventions
- PROCEDURE Muscle Biopsy
- DIETARY_SUPPLEMENT Dextrose
- OTHER Jell-O with Amino acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-08 |
| Phase | NA |
What is known before NCT05985135 opens enrollment
NCT05985135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Muscle Biopsy is the first listed.
NCT05985135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05985135 about?
NCT05985135 is a clinical study titled "Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus". This research is being done to better understand how insulin effects muscle, blood, and the body in people with Type 1 Diabetes.
What is the current status of trial NCT05985135?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-06-01. Estimated completion is 2028-08.
What interventions are being tested in trial NCT05985135?
The interventions under investigation include: Muscle Biopsy (PROCEDURE), Dextrose (DIETARY_SUPPLEMENT), Jell-O with Amino acids (OTHER).
Who is sponsoring clinical trial NCT05985135?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05985135's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI